GB Sciences, Inc. Share Price Other OTC
Equities
GBLX
US3615441090
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.83M 536M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -4M -314M | EV / Sales 2022 | - |
Net Debt 2022 | 1.15M 90.34M | Net Debt 2023 | 1.29M 101M | EV / Sales 2023 | - |
P/E ratio 2022 |
-16.8
x | P/E ratio 2023 |
-1.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.78% |
Managers | Title | Age | Since |
---|---|---|---|
John Poss
CEO | Chief Executive Officer | 76 | 26/07/15 |
President | 54 | 09/06/14 | |
Monica Poss
PRN | Corporate Officer/Principal | - | 31/08/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 54 | 09/06/14 | |
John Poss
CEO | Chief Executive Officer | 76 | 26/07/15 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |